Hepatocellular adenoma differential diagnosis

Jump to navigation Jump to search

Hepatocellular adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatocellular adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular adenoma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular adenoma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular adenoma differential diagnosis

CDC on Hepatocellular adenoma differential diagnosis

Hepatocellular adenoma differential diagnosis in the news

Blogs on Hepatocellular adenoma differential diagnosis

Directions to Hospitals Treating Hepatocellular adenoma

Risk calculators and risk factors for Hepatocellular adenoma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]

Overview

Hepatocellular adenoma differential diagnosis

  • The hepatocellular adenoma must be differentiated from following conditions.
  • Focal nodular hyperplasia
    • Focal nodular hyperplasia represents a hyperplastic response to localized vascular abnormality, consequently it is not a true benign tumor but a benign congenital hemartomatous malformation.
    • It is found in the same age group of patients as hepatocellular adenoma, with a history of oral contraception consumption.
    • Pathologically, focal nodular hyperplasia is usually a solitary, subcapsular and nodular homogenous mass.
    • Unlike hepatocellular adenoma, hemorrhage and necrosis are exceptional within the lesion. No malignant degeneration of focal nodular hyperplasia has been observed.
    • On MRI, a typical scar appears as hyperintense or hypointense stellate area, respectively on T2 and T1 weighted images, it is hypointense during arterial and portal venous phases and slightly hyperintense during equilibrium phase.
  • Large regenerative hyperplasia
    • It is an asymptomatic rare condition characterized by diffuse micronodular transformation of hepatic parenchyma, without fibrous septa between nodules.
    • On MRI T2 images, it is isointense or slightly hypointense, whereas hepatocellular adenoma is hyperintense.
  • Hepatocellular carcinoma in non-cirrhotic patients and fibrolamellar hepatocellular carcinoma
    • These are rare malignant primary liver tumors that arise in young healthy patients of both sexes.
    • Signs of malignancy (vascular and biliary invasion) is not present in hepatocellular adenoma.
  • Cholangiocarcinoma
    • It is the primary malignancy arising from bile duct epithelium and is the second most common liver malignancy after hepatocellular carcinoma.
    • On MR imaging, the cholangiocarcinoma is either hypointense or isointense relative to the normal liver on T1 weighted MR images but may range from mildly or markedly hyperintense on T2 weighted images.
  • Primary lymphoma
    • Primary lymphoma of the liver (confined to liver without involvement of lymph nodes or spleen or bone marrow) is very rare.
    • Hepatomegaly, presence of hepatic mass or masses and pain in right upper quadrant are most frequent signs and symptoms in primary lymphoma.
    • On MR imaging, primary lymphoma is generally seen as homogenously/heterogenously hypointense compared to normal parenchyma on unenhanced T1 weighted images and hyperintense on T2 weighted images.
  • Metastases
    • Metastases are most common cause of malignant focal liver lesions.
    • Liver metastases originate predominantly from primary tumors localized in gastrointestinal tract, by hematogenous spread, via portal vein.
    • On unenhanced T1 weighted images, metastases have low signal intensity compared to surrounding parenchyma.
    • On T2 sequences, the lesions demonstrate high signal intensity, although the signal is generally lower than that typically observed in hemangiomas.

References


Template:WikiDoc Sources